Loading...
Indian Pharmaceutical Exporter · #12 for Meropenem · $500.0K export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #12 Indian exporter of Meropenem with $500.0K in export value and 10 verified shipments. Sun Pharmaceutical Industries Ltd holds a 0.3% market share in Meropenem exports across 6 countries.
| $194.0K |
| 5 |
| 2.2% |
| ZIMBABWE | $130.3K | 7 | 1.5% |
| THAILAND | $118.6K | 3 | 1.3% |
| CANADA | $100.0K | 2 | 1.1% |
| FRANCE | $73.0K | 4 | 0.8% |
| MOROCCO | $71.1K | 3 | 0.8% |
Sun Pharmaceutical Industries Ltd exports Meropenem to 16 countries. The largest destination is BELGIUM accounting for 77.2% of Sun Pharmaceutical Industries Ltd's Meropenem shipments, followed by AUSTRALIA (5.6%) and SOUTH AFRICA (5.0%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $6.2M | 143 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $585.3K | 14 |
| M/S. SUN PHARMA ANZ PTY LTD | AUSTRALIA | $291.1K | 7 |
| M S SANKIL PHARMACEUTICAL LTD | NIGERIA | $150.0K | 3 |
| M/S. RANBAXY PHARMACEUTICALS PTY (L | SOUTH AFRICA | $143.9K | 3 |
| M/S. UAB ABC FARMA | LITHUANIA | $110.8K | 3 |
| M/S. SUN PHARMA CANADA INC | CANADA | $100.0K | 2 |
| SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $100.0K | 2 |
| RANBAXY PHARMACEUTICALS PTY(LT | SOUTH AFRICA | $100.0K | 2 |
| M/S. SUN PHARMACEUTICALS MOROCCO LL | MOROCCO | $60.5K | 2 |
Sun Pharmaceutical Industries Ltd supplies Meropenem to 37 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $80.5M worth of Meropenem through 3,658 shipments from 401 suppliers to 134 countries, serving 966 buyers globally. Sun Pharmaceutical Industries Ltd contributes $500.0K to this total, accounting for 0.3% of India's Meropenem exports. Sun Pharmaceutical Industries Ltd ships Meropenem to 16 countries through 37 buyers.
Sun Pharmaceutical Industries Ltd's average Meropenem shipment value is $50.0K per consignment, based on 10 shipments totaling $500.0K. The largest destination is BELGIUM (77.2% of Sun Pharmaceutical Industries Ltd's Meropenem exports).
Sun Pharmaceutical Industries Ltd ranks #12 among 401 Indian Meropenem exporters with a 0.3% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($40.0M), EUGIA PHARMA SPECIALITIES LIMITED ($17.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.3M). Sun Pharmaceutical Industries Ltd processed 10 shipments to 6 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEROPENEM RANBAXY INJ 1GM (MEROPENEM SUN | $683.9K | 16 |
| MEROPENEM INJ 1GM ( NABLERAN INJ 1000MG | $599.1K | 12 |
| MEROPENEM BASICS-S INJ 1GM PACK : 10 Via | $565.3K | 12 |
| MEROPENEM SUN INJ 1GM PACK : 10 Vials Ba | $443.4K | 9 |
| MEROPENEM SUN INJ 1GM PACK: 10 Vials BAT | $250.0K | 5 |
| MEROPENEM RANBAXY INJ 500MG (MEROPENEM S | $206.0K | 6 |
| MEROPENEM SUN INJ 1G 10X1V 30ML IT PACK | $200.0K | 4 |
| MEROPENEM RANBAXY INJ 1GM(MEROPENEM SUN | $184.9K | 5 |
| MEROPENEM BASICS-S INJ 500MG PACK : 10 V | $168.6K | 5 |
| MEROPENEM RANBAXY 1GM PACK:5 VIALS BATCH | $150.0K | 3 |
Sun Pharmaceutical Industries Ltd exports 109 distinct Meropenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEROPENEM RANBAXY INJ 1GM (MEROPENEM SUN with 16 shipments worth $683.9K.
What Sun Pharmaceutical Industries Ltd must comply with to export Meropenem to its top destination countries
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | M J BIOPHARM PRIVATE LIMITED | $650.0K | 13 | 6 | $50.0K |
| 13 | GLAND PHARMA LTD | $600.0K | 12 | 1 | $50.0K |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $500.0K | 10 | 6 | $50.0K |
| 8 | MAAN PHARMACEUTICALS LIMITED | $150.0K | 3 | 1 | $50.0K |
Sun Pharmaceutical Industries Ltd ranks #12 among 401 Indian Meropenem exporters. Average shipment value of $50.0K compared to the market average of $200.8K. The closest competitors by value are M J BIOPHARM PRIVATE LIMITED and GLAND PHARMA LTD.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 504 | 13.8% |
| DELHI AIR | 494 | 13.5% |
| SAHAR AIR | 256 | 7.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 246 | 6.7% |
| NHAVA SHEVA SEA (INNSA1) | 233 | 6.4% |
| CMA CGM LOGISTICS PARK ICD (INCPL6) | 198 | 5.4% |
| Delhi Air | 103 | 2.8% |
| DHANNAD ICD (INDHA6) | 94 | 2.6% |
Latest developments and market context
Detailed market intelligence for Meropenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 134+ countries, 966+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Meropenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meropenem. For current shipment-level data, contact TransData Nexus.